Pipeline · Bill → Law
Step 1
Introduced
May 25, 2023
Step 2
Referred
May 26, 2023
E&C
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryCRS Summary
This bill authorizes the Food and Drug Administration (FDA) to order the recall of certain adulterated or misbranded drugs and contains other related provisions. A producer of a medication must notify the FDA of the identity and location of a drug if the producer has reason to believe that (1) the drug is adulterated or misbranded, and (2) there is a reasonable probability that the drug will cause a threat of serious adverse health consequences or death to humans or animals. If use of a drug may cause serious adverse health consequences or death, the FDA may order the producer to immediately cease distribution and notify affected individuals. After issuing such an order, the FDA may also o...
Timeline · 3 actions
May 26, 2023
Referred to the Subcommittee on Health.
May 25, 2023
Introduced in House
May 25, 2023
Referred to the House Committee on Energy and Commerce.